EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Taurine and Metabolic Diseases: Molecular Mechanisms and Therapeutic Implications

Xiaojie Ma, Zhijian Rao, Lifang Zheng

Food Frontiers · 2026-09 · 7 (5)

DOI: 10.1002/fft2.70354 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Food Frontiers, online erschienen am 18.08.2026. Verfasst von Xiaojie Ma und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Taurine (Tau) is a sulfur‐containing amino acid prevalent in animal tissues and primarily acquired through dietary sources. Although previously categorized as a conditionally essential amino acid, its significant role in regulating redox balance, inflammatory responses, apoptosis, and metabolic homeostasis has garnered increasing recognition. Unlike focusing on a single disease, this article provides a comprehensive and up‐to‐date overview of the chemical properties, biological functions and supplementary safety of taurine, and particularly clarifies the protective effects and molecular mechanisms of taurine in metabolism‐related diseases such as diabetes and its complications, obesity, non‐alcoholic fatty liver disease, atherosclerosis, tumors, and aging, as well as metabolic disorder‐related ocular and brain injury. Available evidence suggests that taurine acts not only through antioxidant, anti‐inflammatory, and anti‐apoptotic effects, but may also be involved in epigenetic regulation, bile acid–mediated lipid metabolism, and inter‐organ interactions (e.g., gut‐liver axis). While preclinical studies have demonstrated promising therapeutic potential, its clinical translation is currently hindered by a paucity of population‐based evidence, ill‐defined dose‐response relationships (e.g., nonlinear characteristics in specific diseases), and its paradoxical role within specific tumor microenvironments. This article aims to provide a systematic theoretical reference for the in‐depth research and potential clinical application of taurine in the prevention and treatment of metabolic diseases.

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Ma, X., Rao, Z., & Zheng, L. (2026). Taurine and Metabolic Diseases: Molecular Mechanisms and Therapeutic Implications. Food Frontiers, 7(5). https://doi.org/10.1002/fft2.70354

Vancouver

Ma X, Rao Z, Zheng L. Taurine and Metabolic Diseases: Molecular Mechanisms and Therapeutic Implications. Food Frontiers. 2026;7(5). doi:10.1002/fft2.70354

BibTeX
@article{Ma2026,
  author = {Ma, Xiaojie and Rao, Zhijian and Zheng, Lifang},
  title = {Taurine and Metabolic Diseases: Molecular Mechanisms and Therapeutic Implications},
  journal = {Food Frontiers},
  year = {2026},
  volume = {7},
  number = {5},
  doi = {10.1002/fft2.70354}
}
Kostenlos starten →